Actively Recruiting
Evaluation of Pre-Treatment Breast DCE-MRI AI Model to Predict Neoadjuvant Chemotherapy Benefit in Women with Locally Advanced Triple-Negative Breast Cancer
Led by Fujian Cancer Hospital · Updated on 2026-10-19
120
Participants Needed
5
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multicenter, prospective observational study to evaluate how well artificial intelligence AI models based on pre-treatment dynamic contrast-enhanced MRI DCE-MRI scans predict the benefit of neoadjuvant chemotherapy in women with locally advanced triple-negative breast cancer. The study aims to categorize patients into high-benefit and low-benefit groups using this AI model to better understand chemotherapy responsiveness. Participants will receive routine standard neoadjuvant chemotherapy as part of their care. Before chemotherapy, all patients will undergo a DCE-MRI scan, and the AI model will analyze these images to classify their expected benefit from chemotherapy. The study collects clinical data, chemotherapy regimens, and treatment outcomes, including whether the cancer completely responds to therapy, to compare these results within AI-defined subgroups. Throughout the study, participants will provide baseline clinical-pathological information, MRI scans, and biopsy samples. Researchers will monitor treatment response through pathological complete response pCR rates, objective response rates ORR, and long-term outcomes such as disease-free survival DFS and overall survival OS for up to five years. The primary measure is the rate of complete cancer response after chemotherapy and surgery, with secondary analyses evaluating differences between high- and low-benefit groups.
CONDITIONS
Brief Title
Pre-Treatment Breast DCE-MRI AI Model to Predict Neoadjuvant Chemotherapy Benefit in Locally Advanced Triple-Negative Breast Cancer
Research Team
C
Chuangui Song, doctor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here